Literature DB >> 9249059

Distinct repression of translation by wortmannin and rapamycin.

S Pedersen1, J E Celis, J Nielsen, J Christiansen, F C Nielsen.   

Abstract

The role of phosphatidylinositol 3-kinase and FK506-binding protein rapamycin-associated protein (FRAP) in translational control has been examined by treating RD-rhabdomyosarcoma cells with wortmannin and rapamycin and studying the effects on cell-growth, translation initiation, and protein synthesis. Whereas wortmannin and rapamycin exhibit subtle effects on global translation, examination of individual mRNAs in sucrose gradients and of individual proteins in two-dimensional polyacrylamide gels reveals that wortmannin and rapamycin exhibit distinct effects on the translation of individual mRNAs. Wortmannin represses the synthesis of a third of cellular proteins, whereas rapamycin affects a subset of these proteins. Since ribosomal protein S6 was rapidly dephosphorylated following wortmannin and rapamycin treatment, and the phosphorylation status of the eukaryotic initiation factor 4E was unchanged, our data imply that the p70 signalling pathway has at least one branch-point upstream of FRAP leading to an additional route of translational control.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249059     DOI: 10.1111/j.1432-1033.1997.00449.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Ischaemia induces changes in the association of the binding protein 4E-BP1 and eukaryotic initiation factor (eIF) 4G to eIF4E in differentiated PC12 cells.

Authors:  M E Martín; F M Muñoz; M Salinas; J L Fando
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  The TSC-mTOR pathway mediates translational activation of TOP mRNAs by insulin largely in a raptor- or rictor-independent manner.

Authors:  Ilona Patursky-Polischuk; Miri Stolovich-Rain; Mirit Hausner-Hanochi; Judith Kasir; Nadine Cybulski; Joseph Avruch; Markus A Rüegg; Michael N Hall; Oded Meyuhas
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

3.  Cell cycle progression and proliferation despite 4BP-1 dephosphorylation.

Authors:  S O Marx; A R Marks
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  Assessment of mitochondrial biogenesis and mTORC1 signaling during chronic rapamycin feeding in male and female mice.

Authors:  Joshua C Drake; Frederick F Peelor; Laurie M Biela; Molly K Watkins; Richard A Miller; Karyn L Hamilton; Benjamin F Miller
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-05-08       Impact factor: 6.053

5.  Regulation of ribosome biogenesis by the rapamycin-sensitive TOR-signaling pathway in Saccharomyces cerevisiae.

Authors:  T Powers; P Walter
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

Review 6.  An emerging role for TOR signaling in mammalian tissue and stem cell physiology.

Authors:  Ryan C Russell; Chong Fang; Kun-Liang Guan
Journal:  Development       Date:  2011-08       Impact factor: 6.868

Review 7.  Nonsense-mediated RNA decay: an emerging modulator of malignancy.

Authors:  Kun Tan; Dwayne G Stupack; Miles F Wilkinson
Journal:  Nat Rev Cancer       Date:  2022-05-27       Impact factor: 69.800

Review 8.  Rapalogs and mTOR inhibitors as anti-aging therapeutics.

Authors:  Dudley W Lamming; Lan Ye; David M Sabatini; Joseph A Baur
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

9.  Tuberous sclerosis complex proteins 1 and 2 control serum-dependent translation in a TOP-dependent and -independent manner.

Authors:  Benoit Bilanges; Rhoda Argonza-Barrett; Marina Kolesnichenko; Christina Skinner; Manoj Nair; Michelle Chen; David Stokoe
Journal:  Mol Cell Biol       Date:  2007-06-11       Impact factor: 4.272

10.  An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.

Authors:  Carson C Thoreen; Seong A Kang; Jae Won Chang; Qingsong Liu; Jianming Zhang; Yi Gao; Laurie J Reichling; Taebo Sim; David M Sabatini; Nathanael S Gray
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.